SVP Oncology Research, Regeneron Pharmaceuticals
Gavin is a Scientific Advisor at AbTherx. He spent the last 22 years of his career at Regeneron Pharmaceuticals, his most recent position being SVP of Oncology Research. Gavin has authored over 150 publications and is the inventor on over 50 US patents and ongoing patent applications. His efforts at Regeneron led to the successful clinical development of LIBTAYO® and ongoing late-stage clinical testing of several other antibodies and bispecific antibodies. In addition to his advisory role at AbTherx, Gavin is also doing consulting work on several other antibody and bispecifc projects.
Gavin earned a Doctor of Philosophy degree in biophysics from the University of British Columbia, Vancouver, Canada, and a postdoctoral research fellowship in tumor vasculature at CRC Gray Laboratory, London, England.